Novel findings shed light on the role of tumor necrosis factor in ankylosis and inflammation, pointing to new indications for blockade of this cytokine in treating spondyloarthritis. At the

same time, the identification of other potential targets for therapy could expand the treatment options for this family of inflammatory disorders. Access through your institution Buy or

subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online

access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which

777–783 (2009). Article  CAS  Google Scholar  * Rudwaleit, M. _ et al_. The Assessment of SpondyloArthritis International Society (ASAS) classification criteria for peripheral

spondyloarthritis and for spondyloarthritis in general. _Ann. Rheum. Dis._ 70, 25–31 (2011). Article  CAS  Google Scholar  * Rudwaleit, M., Khan, M. A. & Sieper, J. The challenge of

diagnosis and classification in early ankylosing spondylitis: do we need new criteria? _Arthritis Rheum._ 52, 1000–1008 (2005). Article  Google Scholar  * van der Heijde, D. _ et al_.

Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. _Arthritis Rheum._ 58, 3063–3070 (2008). Article  Google Scholar  * Sieper, J.,

Appel, H., Braun, J. & Rudwaleit, M. Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. _Arthritis Rheum._ 58, 649–656

(2008). Article  Google Scholar  * Diarra, D. _ et al_. Dickkopf-1 is a master regulator of joint remodeling. _Nat. Med._ 13, 156–163 (2007). Article  CAS  Google Scholar  * Uderhardt, S. _

et al_. Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints. _Ann. Rheum. Dis._ 69, 592–597 (2010). Article  CAS  Google Scholar  * Dougados, M. _ et al_. A randomised,

multicenter, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial. _Ann. Rheum. Dis._ 69, 1430–1435 (2010).

Article  CAS  Google Scholar  * Carter, J. D. _ et al_. Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. _Arthritis Rheum._ 60, 1311–1316 (2009). Article  Google

Scholar  * Carter, J. D. _ et al_. Combination antibiotics as a treatment for chronic _Chlamydia_-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial.

_Arthritis Rheum._ 62, 1298–1307 (2010). Article  CAS  Google Scholar  Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Medicine, Rheumatology, Charité Campus

Benjamin Franklin, Hindenburgdamm 30, Berlin, 12200, Germany Joachim Sieper Authors * Joachim Sieper View author publications You can also search for this author inPubMed Google Scholar

ETHICS DECLARATIONS COMPETING INTERESTS J. Sieper has acted as a consultant for and has received grant support and/or honoraria from Abbott, Merck and Pfizer. RIGHTS AND PERMISSIONS Reprints

and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Sieper, J. New insights into therapy—TNF blockade and beyond. _Nat Rev Rheumatol_ 7, 78–80 (2011).

https://doi.org/10.1038/nrrheum.2010.224 Download citation * Published: 02 February 2011 * Issue Date: February 2011 * DOI: https://doi.org/10.1038/nrrheum.2010.224 SHARE THIS ARTICLE Anyone

you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by

the Springer Nature SharedIt content-sharing initiative